|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
136,480,000 |
Market
Cap: |
3.66(B) |
Last
Volume: |
503,160 |
Avg
Vol: |
501,799 |
52
Week Range: |
$26.23 - $39.94 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Perrigo is a provider of over-the-counter health and wellness solutions that can be self-managed. Co.'s segments are as follows: Consumer Self-Care Americas, which is focused primarily on the sale of self-care products in categories including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements; Consumer Self-Care International, which develops, manufactures, markets, and distributes European consumer self-care brands in the upper respiratory, pain and sleep-aids, digestive health, vitamins, minerals and supplements; and Prescription Pharmaceuticals, which develops, manufactures, and markets a portfolio of generic prescription drugs.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kochan Sharon |
Executive VP U.S. Generics |
|
2011-03-02 |
4 |
OE |
$14.69 |
$112,125 |
D/D |
7,500 |
11,925 |
|
- |
|
Arkin Moshe |
Director |
|
2011-03-02 |
4 |
S |
$76.38 |
$5,963,132 |
I/I |
(77,901) |
6,043,323 |
|
- |
|
Jandernoa Michael J |
Director |
|
2011-03-02 |
4 |
S |
$76.46 |
$301,388 |
D/D |
(3,942) |
6,245 |
|
- |
|
Jandernoa Michael J |
Director |
|
2011-03-02 |
4 |
OE |
$14.12 |
$55,661 |
D/D |
3,942 |
10,187 |
|
- |
|
Jandernoa Michael J |
Director |
|
2011-03-02 |
4 |
GD |
$0.00 |
$0 |
I/I |
270 |
1,059,984 |
|
- |
|
Arkin Moshe |
Director |
|
2011-03-01 |
4 |
S |
$76.48 |
$3,826,546 |
I/I |
(50,000) |
6,121,224 |
|
- |
|
Arkin Moshe |
Director |
|
2011-02-28 |
4 |
S |
$76.16 |
$2,628,441 |
D/D |
(34,513) |
1,130 |
|
- |
|
Arkin Moshe |
Director |
|
2011-02-28 |
4 |
OE |
$14.69 |
$729,386 |
D/D |
34,513 |
35,643 |
|
- |
|
Arkin Moshe |
Director |
|
2011-02-28 |
4 |
S |
$76.19 |
$3,809,665 |
I/I |
(50,000) |
6,171,224 |
|
- |
|
Arkin Moshe |
Director |
|
2011-02-25 |
4 |
S |
$75.28 |
$3,312,934 |
I/I |
(43,874) |
6,221,224 |
|
- |
|
Jandernoa Michael J |
Director |
|
2011-02-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
142 |
1,060,254 |
|
- |
|
Papa Joseph C |
President and CEOChairman |
|
2011-02-22 |
4 |
AS |
$74.84 |
$1,574,709 |
D/D |
(21,000) |
115,337 |
|
- |
|
Papa Joseph C |
President and CEOChairman |
|
2011-02-22 |
4 |
OE |
$17.29 |
$259,350 |
D/D |
15,000 |
130,337 |
|
- |
|
Arkin Moshe |
Director |
|
2011-02-22 |
4 |
S |
$74.41 |
$4,189,471 |
I/I |
(56,126) |
6,265,098 |
|
- |
|
Brown Judy L |
Executive VP & CFO |
|
2011-02-18 |
4 |
S |
$75.84 |
$151,682 |
D/D |
(2,000) |
18,133 |
|
- |
|
Arkin Moshe |
Director |
|
2011-02-18 |
4 |
S |
$75.69 |
$15,138,420 |
I/I |
(200,000) |
6,321,224 |
|
- |
|
Arkin Moshe |
Director |
|
2011-02-17 |
4 |
S |
$75.16 |
$6,653,991 |
D/D |
(87,651) |
1,130 |
|
- |
|
Arkin Moshe |
Director |
|
2011-02-16 |
4 |
S |
$74.68 |
$14,957,900 |
I/I |
(200,000) |
6,521,224 |
|
- |
|
Kingma Todd W |
Executive VP, General Counsel |
|
2011-02-16 |
4 |
S |
$74.56 |
$298,241 |
D/D |
(4,000) |
20,345 |
|
- |
|
Hendrickson John T |
EVP Global Operations & Supply |
|
2011-02-16 |
4 |
S |
$75.06 |
$375,306 |
I/I |
(5,000) |
56,279 |
|
- |
|
Shah Jatin |
Sr VP & Chief Scientific Offic |
|
2011-02-16 |
4 |
S |
$74.58 |
$149,166 |
D/D |
(2,000) |
5,477 |
|
- |
|
Jandernoa Michael J |
Director |
|
2011-02-15 |
4 |
GD |
$0.00 |
$0 |
I/I |
36 |
1,060,396 |
|
- |
|
Jandernoa Michael J |
Director |
|
2011-02-15 |
4 |
S |
$73.67 |
$2,444,791 |
I/I |
(33,184) |
1,069,215 |
|
- |
|
Jandernoa Michael J |
Director |
|
2011-02-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
156 |
1,060,432 |
|
- |
|
Jandernoa Michael J |
Director |
|
2011-02-14 |
4 |
S |
$73.75 |
$2,215,507 |
I/I |
(30,000) |
1,102,399 |
|
- |
|
1400 Records found
|
|
Page 22 of 56 |
|
|